Bristol Myers Squibb Co. (BMY)
60.27
-0.47
(-0.77%)
USD |
NYSE |
Mar 06, 16:00
60.21
-0.06
(-0.10%)
After-Hours: 18:19
Bristol Myers Squibb Free Cash Flow : 12.84B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Janux Therapeutics, Inc. | -83.28M |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.974B |
| Cash from Investing (Quarterly) | -1.458B |
| Cash from Financing (Quarterly) | -6.029B |
| Free Cash Flow Per Share (Quarterly) | 0.7859 |
| Free Cash Flow to Equity (Quarterly) | 5.506B |
| Free Cash Flow to Firm (Quarterly) | 1.923B |
| Free Cash Flow Yield | 10.45% |